How Could Oregon-style Healthcare Reform Satisfy Liberals, Conservatives and Libertarians?

Can Liberals, Conservatives and Libertarians find common ground on an approach to reforming healthcare? - If you are Libertarian, click here. - If you are Liberal, click here. - If you are Conservative, click here. Jump to Summary Conclusion For Libertarians For Libertarians For Libertarians Americans are divided politically, now perhaps more so than at … Continue reading How Could Oregon-style Healthcare Reform Satisfy Liberals, Conservatives and Libertarians?

FAQ: What Are the Strongest Criticisms of the Oregon Health Plan for Healthcare Reform?

Fixing US Healthcare blog has touted the Oregon Health Plan of 1994 as a model of U.S. healthcare reform. But what are the strongest criticisms of OHP? Let’s look at 8 criticisms from 3 critics. Which criticisms are valid and which ones questionable? Finally, what about ethics? Jonathan Oberlander PhD: 5 Criticisms The first critic … Continue reading FAQ: What Are the Strongest Criticisms of the Oregon Health Plan for Healthcare Reform?

Will New Trump-GOP Tax Plan Trigger PAYGO Cuts to Medicare?

The Trump-GOP tax plan will add to the national debt by $1 trillion (Joint Committee on Taxation) or $1.4 trillion (Congressional Budget Office). Under the pay-as-you-go (PAYGO) law, Congress will need to make a choice to cut Medicare or to allow the increase of the national debt. The PAYGO law says that the revenue shortfall … Continue reading Will New Trump-GOP Tax Plan Trigger PAYGO Cuts to Medicare?

FAQ: How Would Cost-Benefit Analysis Be Used to Restrain Healthcare Costs? – The Case of an Expensive New Cholesterol Drug

Executive Summary Some experts say that cost-benefit analysis is the way to restrain soaring healthcare costs and reform the system. How exactly would cost-benefit analysis work? This blog argues: Forget the caviar.  But keep costworthy care on the menu. To explain what this means, let’s look at the case of Repatha (evolocumab), the new cholesterol-lowering drug, … Continue reading FAQ: How Would Cost-Benefit Analysis Be Used to Restrain Healthcare Costs? – The Case of an Expensive New Cholesterol Drug

Navigating Payment Reform – NEJM Catalyst

Harvard Business School and New England Journal of Medicine Catalyst group convened a webinar on “Navigating Payment Reform for Providers, Payers & Pharma” on November 2. Presenters admirably fulfilled Dr. Dafny’s challenge as convener to be transparent about goals, attuned to new ideas, open to trade-offs, and unafraid of failure. From the perspective of General Systems … Continue reading Navigating Payment Reform – NEJM Catalyst